0001209191-18-018361.txt : 20180308
0001209191-18-018361.hdr.sgml : 20180308
20180308204049
ACCESSION NUMBER: 0001209191-18-018361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180306
FILED AS OF DATE: 20180308
DATE AS OF CHANGE: 20180308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cotroneo Pat
CENTRAL INDEX KEY: 0001621334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 18678297
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.,
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER NAME:
FORMER CONFORMED NAME: Controneo Pat
DATE OF NAME CHANGE: 20141002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-06
0
0000921299
FIBROGEN INC
FGEN
0001621334
Cotroneo Pat
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
0
1
0
0
VP, Finance and CFO
Common Stock
2018-03-06
4
F
0
5832
53.55
D
176160
D
Common Stock
2018-03-08
4
S
0
906
52.68
D
175254
D
Common Stock
2018-03-08
4
S
0
909
53.45
D
174345
D
Common Stock
2018-03-08
4
S
0
79
54.47
D
174266
D
Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $52.10 to $53.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $53.10 to $53.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $54.10 to $54.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Dorothy Pacini, Attorney-in-fact
2018-03-08